Last $295.70 USD
Change Today -0.44 / -0.15%
Volume 2.2M
As of 8:04 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul M. Bisaro

Executive Chairman, Actavis plc
AgeTotal Calculated CompensationThis person is connected to 41 board members in 5 different organizations across 9 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Paul M. Bisaro has been the Chief Executive Officer, President and Chairman at Actavis Limited since October 2013. Mr. Bisaro served as Chief Executive Officer of Actavis plc since September 4, 2007. He served as the President of Actavis plc since September 4, 2007. He served as the President and Chief Operating Officer of Barr Pharmaceuticals Inc. from December 1999 to August 2007. He joined the Barr Pharmaceuticals Inc. in 1992 and served as its General Counsel ...

Read Full Background

Corporate Headquarters*

Morris Corporate Center III
Parsippany, New Jersey 07054

United States

Phone: --
Fax: --

Board Members Memberships*

Independent Director
Former President, Chief Operating Officer, Director, President of New BLI and Chief Operating Officer of New BLI
Executive Chairman
Independent Director, Member of Compensation & Management Development Committee and Member of Corporate Governance Committee
Chairman, Chief Executive Officer and President


Bachelor's Degree 1983
University of Michigan
JD 1989
Catholic University of America

Other Affiliations*

Annual Compensation*

Total Annual Compensation$2,595,673

Stock Options*

Restricted Stock Awards$6,011,652
All Other Compensation$92,497
Exercised Options527,200
Exercised Options Value$55,234,744
Total Value of Options$55,234,744
Total Number of Options527,200

Total Compensation*

Total Annual Cash Compensation$5,369,420
Total Short Term Compensation$2,595,673
Other Long Term Compensation$6,104,149
Total Calculated Compensation$11,381,072
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACT:US $295.70 USD -0.44


Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Yasuchika Hasegawa Chairman and Chief Executive Officer
Takeda Pharmaceutical Company Limited
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTAVIS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at